# MediTrack Solutions - Risk Assessment Worksheet

## Risk Assessment Information

**Date of Assessment:** June 12, 2023  
**Assessment Team:** Sarah Chen (CISO), Mark Johnson (CTO), Priya Patel (Compliance Officer), David Rodriguez (Product Manager), Lisa Wong (Operations Manager)  
**Review Schedule:** Annual, with quarterly reviews of high-risk items

## Risk Assessment Section

| Risk - What might affect confidentiality, availability or integrity | Risk owner | Why is this a threat/risk? | Estimate Consequence (1-5) | Estimate Probability (1-5) | Why is the probability of this assessed? | Calculated risk (C×P) | Accepted (Yes/No/Avoid) |
|------------------------------------------------------------------|------------|---------------------------|---------------------------|----------------------------|------------------------------------------|----------------------|------------------------|
| **CONFIDENTIALITY RISKS** |  |  |  |  |  |  |  |
| Unauthorized access to patient health information | CISO | Patient data is subject to privacy regulations; breaches can result in regulatory penalties, reputation damage, and legal liability | 5 | 3 | Despite access controls, the growing attack surface with mobile access and third-party integrations increases risk. Historical data shows healthcare is a prime target for attacks. | 15 | Avoid |
| Improper handling of PHI data in test environments | CTO | Test environments occasionally use copies of production data with PHI, creating risk of unauthorized access or exposure | 4 | 4 | Current practices allow developers to use production data copies for testing without complete anonymization. Limited controls are in place for test environment access. | 16 | Avoid |
| Data exposure through third-party integrations | Integration Manager | Healthcare facility integrations with varying security standards could lead to data leakage or unauthorized access | 5 | 3 | Custom connectors have different security levels; third-party security practices are not consistently audited or validated | 15 | Avoid |
| **INTEGRITY RISKS** |  |  |  |  |  |  |  |
| Corruption of medication dosage data | Product Manager | Incorrect medication dosages could lead to patient harm, liability, and reputation damage | 5 | 2 | Multiple validation checks exist, but software updates or database errors could still impact data integrity | 10 | Avoid |
| Unauthorized modification of inventory records | Operations Manager | Manipulation of inventory data could lead to medication shortages, financial losses, or controlled substance diversion | 4 | 2 | Access controls and audit trails exist, but increasing system complexity and user base expands potential attack vectors | 8 | No |
| Software update errors affecting data integrity | Development Manager | Bugs or errors in biweekly updates could corrupt critical patient or medication data | 4 | 3 | Regular update cycles with fast development timelines increase risk despite QA processes | 12 | Avoid |
| **AVAILABILITY RISKS** |  |  |  |  |  |  |  |
| System outage affecting real-time medication tracking | Operations Manager | Healthcare facilities rely on real-time medication tracking; outages could disrupt patient care and create safety risks | 5 | 2 | Redundancy exists but system complexity and third-party dependencies create residual risk | 10 | Avoid |
| Database performance issues during peak usage | CTO | Slow performance during high-demand periods could delay medication administration or create data recording gaps | 3 | 3 | Current architecture handles typical load but may struggle during peak times across multiple facilities | 9 | Yes |
| Loss of connectivity with client hospital systems | Integration Manager | Connectivity issues could prevent data synchronization between MediTrack and client EHR systems | 4 | 3 | Multiple integration points with various client technologies create numerous potential failure points | 12 | Avoid |
| **COMPLIANCE RISKS** |  |  |  |  |  |  |  |
| Failure to meet healthcare data protection regulations | Compliance Officer | Non-compliance with healthcare privacy laws could result in significant fines, sanctions, and reputation damage | 5 | 2 | Regular compliance reviews are performed, but regulations are complex and evolving | 10 | Avoid |
| Inadequate audit trails for regulatory reporting | CISO | Insufficient activity logging could hamper investigations and fail to meet compliance requirements | 4 | 2 | Current logging is comprehensive but not regularly reviewed for completeness or gaps | 8 | No |
| Non-compliance with client security requirements | Compliance Officer | Clients may have stricter security requirements than MediTrack's baseline, leading to contract breaches | 3 | 3 | Client security requirements vary widely and are not systematically tracked across all clients | 9 | Yes |

## Risk Management Section

| Risk | Calculated risk | Accepted | New measures | Consequences after new measures | New probability | New residual risk | Accepted | Conclusion | Willingness to take risk | Explanation |
|------|----------------|----------|--------------|--------------------------------|----------------|-------------------|----------|------------|-------------------------|-------------|
| Unauthorized access to patient health information | 15 | Avoid | Implement enhanced MFA, privileged access management, advanced threat monitoring, and quarterly access reviews. Conduct additional security awareness training with simulated phishing. | 5 | 2 | 10 | No | Additional security measures required: investigate data loss prevention solutions and consider a Zero Trust architecture | Red | Management has zero tolerance for PHI breaches. Further work needed to reduce risk below 10. |
| Improper handling of PHI data in test environments | 16 | Avoid | Implement data masking/anonymization for all test data. Create separate test data generator. Institute strict policies prohibiting production data in test environments. Conduct developer training on secure testing practices. | 4 | 1 | 4 | Yes | Test environment will be redesigned to use only synthetic or fully anonymized data | Green | With anonymization and proper controls, risk becomes acceptable |
| Data exposure through third-party integrations | 15 | Avoid | Implement API gateway with enhanced security controls. Require security assessments for all third-party integrations. Develop standardized security requirements for all integration partners. Add data loss prevention monitoring. | 5 | 2 | 10 | No | Will require additional measures including regular penetration testing of integration points and security architecture review | Red | Management requires additional assurance for third-party data handling |
| Corruption of medication dosage data | 10 | Avoid | Implement additional validation checks, data checksums, and reconciliation processes. Add automated monitoring for data anomalies. Enhance QA processes for data integrity. | 5 | 1 | 5 | Yes | Enhanced validation processes with automated verification will make data corruption highly unlikely | Green | Critical patient safety issue requires stringent controls |
| Unauthorized modification of inventory records | 8 | No | Enhance audit logging for all inventory changes. Implement segregation of duties for inventory management. Add anomaly detection for unusual patterns. | 4 | 1 | 4 | Yes | Additional controls make unauthorized modifications easily detectable and significantly less likely | Green | Controls are sufficient to reduce probability to acceptable levels |
| Software update errors affecting data integrity | 12 | Avoid | Implement staged rollout process. Enhance automated testing. Add automated rollback capabilities. Implement data integrity checks pre- and post-deployment. | 4 | 2 | 8 | Yes | Enhanced deployment processes with integrity verification significantly reduce risk | Yellow | Periodic review of deployment process will be conducted |
| System outage affecting real-time medication tracking | 10 | Avoid | Implement enhanced redundancy across multiple availability zones. Improve failover automation. Develop client-side offline capabilities with synchronization. | 4 | 1 | 4 | Yes | Enhanced infrastructure with redundancy makes extended outages unlikely | Green | Safety-critical system requires high availability |
| Database performance issues during peak usage | 9 | Yes | Schedule optimization and performance tuning. Implement read replicas and caching strategies. Monitor performance proactively with alerts. | 3 | 2 | 6 | Yes | Performance optimizations should provide sufficient capacity for peak loads | Yellow | Ongoing monitoring will help identify trends before they become critical |
| Loss of connectivity with client hospital systems | 12 | Avoid | Develop store-and-forward capabilities. Implement client-side caching. Create redundant connectivity options. Deploy enhanced connectivity monitoring. | 3 | 2 | 6 | Yes | Improved architecture makes connectivity issues manageable with minimal impact | Yellow | While not eliminated, impact is significantly reduced |
| Failure to meet healthcare data protection regulations | 10 | Avoid | Engage external compliance consultant for gap analysis. Implement continuous compliance monitoring. Develop regulatory change management process. | 5 | 1 | 5 | Yes | Proactive compliance management makes regulatory violations unlikely | Green | Enhanced compliance program addresses regulatory risks |
| Inadequate audit trails for regulatory reporting | 8 | No | Implement centralized logging platform. Develop automated audit log monitoring. Create regular audit log review process. | 3 | 1 | 3 | Yes | Comprehensive logging system with regular reviews addresses audit requirements | Green | Advanced logging meets compliance requirements |
| Non-compliance with client security requirements | 9 | Yes | Create client security requirement tracking system. Perform compliance gap analysis for each client. Develop standardized security requirements that meet or exceed typical client needs. | 3 | 2 | 6 | Yes | Systematic tracking and proactive management of client requirements reduces compliance gaps | Yellow | Regular reviews will ensure ongoing compliance |

## Risk Classification Reference

### Consequence Scale
1. **Very small consequence** – It is really of no significance
2. **Small consequence** – It can be handled as part of normal operations
3. **Some consequence** – Extra resources will probably have to be found
4. **High consequence** – It has an impact on the bottom line
5. **Very large consequence** – The company is threatened

### Probability Scale
1. **Rare or unlikely** – Very low probability of occurrence
2. **Will hardly occur** – Low probability of occurrence
3. **Is possible** – Moderate probability of occurrence
4. **Must be expected to happen** – High probability of occurrence
5. **Will be exploited** – Very high probability of occurrence

### Risk Acceptance Levels
* **Green** (1-5): Low risk, can be immediately accepted
* **Yellow** (6-9): Medium risk, requires periodic review
* **Red** (10+): High risk, requires action

## Risk Assessment Approach

### Step 1: Define Risk Assessment Parameters
Considering MediTrack's business context, assess risks with special attention to:
- Patient data privacy and regulatory requirements
- Potential impact on patient safety
- System availability required for healthcare operations
- Reputation with healthcare clients

### Step 2: Identify Critical Assets
Focus on the five critical IT systems:
- Patient Data Repository
- Medication Inventory System
- User Management System
- Reporting & Analytics Engine
- Mobile App Backend

### Step 3: Assign Risk Owners
Appropriate risk owners might include:
- CTO for technical infrastructure
- CISO for security matters
- Compliance Officer for regulatory issues
- Product Manager for software functionality
- Operations Manager for service delivery

### Step 4: Identify Threats and Vulnerabilities
Consider MediTrack's specific vulnerabilities:
- Test environment with production data
- Mobile app security dependencies
- Third-party component vulnerabilities
- Expanded remote work attack surface
- Custom client integration connectors

### Steps 5-6: Determine Consequences and Assess Likelihood
For each identified risk, assess:
- Potential business impact (1-5)
- Probability of occurrence (1-5)
- Current controls effectiveness

## Notes for Risk Management Plan

When developing mitigation strategies, consider:

1. **Immediate Actions Required**
   - Implement data masking/anonymization for test environments (HIGH PRIORITY)
   - Develop enhanced validation processes for medication dosage data
   - Implement privileged access management for PHI access
   - Conduct security assessments for all third-party integrations

2. **Medium-Term Improvements**
   - Deploy centralized logging and monitoring platform
   - Implement enhanced infrastructure redundancy
   - Develop client security requirement tracking system
   - Enhance deployment processes with automated integrity checks

3. **Long-Term Security Enhancements**
   - Transition to Zero Trust security architecture
   - Develop advanced data loss prevention program
   - Implement AI-based anomaly detection
   - Redesign integration architecture with enhanced security by design

4. **Risk Monitoring Schedule**
   - Red risks: Review monthly
     - Unauthorized access to patient health information
     - Data exposure through third-party integrations
   - Yellow risks: Review quarterly
     - Software update errors affecting data integrity
     - Database performance issues during peak usage
     - Loss of connectivity with client hospital systems
     - Non-compliance with client security requirements
   - Green risks: Review annually
     - Improper handling of PHI data in test environments (after mitigations)
     - Corruption of medication dosage data (after mitigations)
     - Unauthorized modification of inventory records
     - System outage affecting real-time medication tracking (after mitigations)
     - Failure to meet healthcare data protection regulations (after mitigations)
     - Inadequate audit trails for regulatory reporting

---

*Template provided for educational purposes. Adapt as needed for your specific risk assessment requirements.* 